Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    StockNews24StockNews24
    Subscribe
    • Shares
    • News
      • Featured Company
      • News Overview
        • Company news
        • Expert Columns
        • Germany
        • USA
        • Price movements
        • Default values
        • Small caps
        • Business
      • News Search
        • Stock News
        • CFD News
        • Foreign exchange news
        • ETF News
        • Money, Career & Lifestyle News
      • Index News
        • DAX News
        • MDAX News
        • TecDAX News
        • Dow Jones News
        • Eurostoxx News
        • NASDAQ News
        • ATX News
        • S&P 500 News
      • Other Topics
        • Private Finance News
        • Commodity News
        • Certificate News
        • Interest rate news
        • SMI News
        • Nikkei 225 News1
    • Carbon Markets
    • Raw materials
    • Funds
    • Bonds
    • Currency
    • Crypto
    • English
      • العربية
      • 简体中文
      • Nederlands
      • English
      • Français
      • Deutsch
      • Italiano
      • Português
      • Русский
      • Español
    StockNews24StockNews24
    Home » Nvidia’s stock has been a huge S&P 500 driver. Here’s why its influence could wane.
    Uncategorized

    Nvidia’s stock has been a huge S&P 500 driver. Here’s why its influence could wane.

    By September 9, 2024No Comments1 Min Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    With more Nvidia earnings growth ahead, Citi says the company should still help the S&P 500’s performance, though potentially not to the same extent as before.

    Share this:

    • Click to share on Facebook (Opens in new window) Facebook
    • Click to share on X (Opens in new window) X

    Like this:

    Like Loading...

    Related

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleSummit Therapeutics’ stock pops as lung-cancer treatment beats Merck blockbuster in late-stage trial
    Next Article Terns Pharmaceuticals’ stock soars 26% after biotech posts positive results in trial of weight-loss drug in pill form

    Related Posts

    What’s the Worth of Meta’s Massive Carbon Credit Deal with BTG Pactual?

    September 20, 2024

    Oceanic life found to be thriving thanks to Saharan dust blown from thousands of kilometers away

    September 20, 2024

    Carbon tax on fuel may soon be axed but expect other climate charges to stay

    September 20, 2024
    Add A Comment

    Leave a ReplyCancel reply

    © 2025 StockNews24. Designed by Sujon.

    Type above and press Enter to search. Press Esc to cancel.

    %d